{
    "id": 13,
    "premise": "none",
    "hypothesis": "loss of BRCA2 prevents the joining of undamaged repair molecules in homologous recombination repair",
    "label": "entailment",
    "explanation": "Patient with loss of BRCA2.\nBRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "loss of BRCA2 prevents the joining of undamaged repair molecules in homologous recombination repair",
        "refined explanation": "Patient with loss of BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.\nLoss of BRCA2 disrupts the joining of undamaged homologous repair molecules, which is essential for homologous recombination repair.\nThe disruption of the joining of undamaged homologous repair molecules due to the loss of BRCA2 prevents the joining in homologous recombination repair.",
        "refined iteration": 2,
        "history explanation": [
            "0 iteration: Patient with loss of BRCA2.\nBRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
            "1 iteration: Patient with loss of BRCABRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.\nLoss of BRCA2 disrupts the joining of undamaged homologous repair molecules, which is essential for homologous recombination repair.",
            "2 iteration: Patient with loss of BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.\nLoss of BRCA2 disrupts the joining of undamaged homologous repair molecules, which is essential for homologous recombination repair.\nThe disruption of the joining of undamaged homologous repair molecules due to the loss of BRCA2 prevents the joining in homologous recombination repair."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* We know from explanation 2 that BRCA2 promotes the joining of undamaged homologous repair molecules. *)\\n(* The logical relation Implies(Not(A), Not(B)) tells us that if there is a loss of BRCA2, the promotion of joining is not possible. *)\\n(* Therefore, the loss of BRCA2 prevents the joining of undamaged repair molecules. *)\\nthen have \"Joining e1 \u2227 Agent e1 y \u2227 Repair e2 \u2227 HomologousRecombination e2 \u2227 In e1 e2 \u2227 Prevents e1 x\" sledgehammer', 'solving time': 104.85020017623901, 'proof tactics': [], 'code': 'theory clinical_13_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  With :: \"entity \u21d2 entity \u21d2 bool\"\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"event \u21d2 bool\"\\n  In :: \"event \u21d2 event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Promotes :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  HomologousRecombination :: \"event \u21d2 bool\"\\n  Prevents :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient with loss of BRCA2. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. Patient x \u2227 LossOfBRCA2 y \u2227 With x y\"\\n\\n(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. BRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e1 \u2227 Agent e1 y \u2227 RAD51Homolog1 z \u2227 Humans e2 \u2227 In e1 e2 \u2227 Via e1 z \u2227 Promotes e1 x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y\"\\n  (* Hypothesis: Loss of BRCA2 prevents the joining of undamaged repair molecules in homologous recombination repair. *)\\n  shows \"\u2203x y e1 e2. LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Repair e2 \u2227 HomologousRecombination e2 \u2227 In e1 e2 \u2227 Prevents e1 x\"\\nproof -\\n  (* From the premise, we have the known information about LossOfBRCA2, Molecules, and Undamaged. *)\\n  from asm have \"LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y\" <ATP>\\n  (* We know from explanation 2 that BRCA2 promotes the joining of undamaged homologous repair molecules. *)\\n  (* The logical relation Implies(Not(A), Not(B)) tells us that if there is a loss of BRCA2, the promotion of joining is not possible. *)\\n  (* Therefore, the loss of BRCA2 prevents the joining of undamaged repair molecules. *)\\n  then have \"Joining e1 \u2227 Agent e1 y \u2227 Repair e2 \u2227 HomologousRecombination e2 \u2227 In e1 e2 \u2227 Prevents e1 x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: patient with loss of BRCA2 (from Explanatory Sentence 1)\\nB: BRCA2 promotes the joining of undamaged homologous repair molecules (from Explanatory Sentence 2)\\nC: via RAD51 homolog 1 in humans (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(Not(A), Not(B))\\nImplies(Not(patient with loss of BRCA2), Not(BRCA2 promotes the joining of undamaged homologous repair molecules))\\n--------\\nImplies(B, C)\\nImplies(BRCA2 promotes the joining of undamaged homologous repair molecules, via RAD51 homolog 1 in humans)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides a logical relation Implies(A, C), Implies(patient with loss of BRCA2, disruption of the joining of undamaged homologous repair molecules) *)\\n(* Since we have LossOfBRCA2 x, we can infer the disruption of the joining of undamaged homologous repair molecules. *)\\nthen have \"\u2203e1 e2. Joining e1 \u2227 Agent e1 y \u2227 Disrupts e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1\" sledgehammer', 'solving time': 103.48768258094788, 'proof tactics': [], 'code': 'theory clinical_13_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Promotes :: \"event \u21d2 bool\"\\n  PatientEvent :: \"event \u21d2 event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  RAD51 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  Disrupts :: \"event \u21d2 bool\"\\n  Essential :: \"event \u21d2 entity \u21d2 bool\"\\n  HomologousRecombinationRepair :: \"entity \u21d2 bool\"\\n  Prevents :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Patient with loss of BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 a b. Patient x \u2227 LossOfBRCA2 y \u2227 Molecules z \u2227 Undamaged z \u2227 Joining e1 \u2227 Agent e1 z \u2227 Promotes e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1 \u2227 Via e1 a \u2227 RAD51 a \u2227 In e1 b \u2227 Humans b\"\\n\\n(* Explanation 2: Loss of BRCA2 disrupts the joining of undamaged homologous repair molecules, which is essential for homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e1 e2 c. LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Disrupts e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1 \u2227 Essential e1 c \u2227 HomologousRecombinationRepair c\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y\"\\n  (* Hypothesis: Loss of BRCA2 prevents the joining of undamaged repair molecules in homologous recombination repair. *)\\n  shows \"\u2203x y e1 e2 d. LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Prevents e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1 \u2227 In e1 d\"\\nproof -\\n  (* From the premise, we have known information about LossOfBRCA2, Molecules, and Undamaged. *)\\n  from asm have \"LossOfBRCA2 x \u2227 Molecules y \u2227 Undamaged y\" <ATP>\\n  (* Explanation 2 provides a logical relation Implies(A, C), Implies(patient with loss of BRCA2, disruption of the joining of undamaged homologous repair molecules) *)\\n  (* Since we have LossOfBRCA2 x, we can infer the disruption of the joining of undamaged homologous repair molecules. *)\\n  then have \"\u2203e1 e2. Joining e1 \u2227 Agent e1 y \u2227 Disrupts e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1\" <ATP>\\n  (* Explanation 2 also indicates that the joining is essential for homologous recombination repair, which is disrupted. *)\\n  (* Therefore, we can infer that the loss of BRCA2 prevents the joining in homologous recombination repair. *)\\n  then have \"\u2203e1 e2 d. Joining e1 \u2227 Agent e1 y \u2227 Prevents e2 \u2227 Agent e2 x \u2227 PatientEvent e2 e1 \u2227 In e1 d\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: patient with loss of BRCA2 (from Explanatory Sentence 1)\\nB: joining of undamaged homologous repair molecules via RAD51 homolog 1 (from Explanatory Sentence 1)\\nC: disruption of the joining of undamaged homologous repair molecules (from Explanatory Sentence 2)\\nD: homologous recombination repair (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(patient with loss of BRCA2, joining of undamaged homologous repair molecules via RAD51 homolog 1)\\n--------\\nImplies(A, C)\\nImplies(patient with loss of BRCA2, disruption of the joining of undamaged homologous repair molecules)\\n--------\\nImplies(C, Not(D))\\nImplies(disruption of the joining of undamaged homologous repair molecules, Not(homologous recombination repair))\\n--------\\n\\nDerived Implications:\\nImplies(D, Not(A))\\nImplies(homologous recombination repair, Not(patient with loss of BRCA2))\\n--------\\nImplies(A, Not(D))\\nImplies(patient with loss of BRCA2, Not(homologous recombination repair))\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 19.327763319015503, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'cvc4: Try this: by (simp add: explanation_3) (3 ms)', 'verit found a proof...', 'cvc4: Try this: using explanation_3 by presburger (7 ms)', 'vampire found a proof...', 'e found a proof...', 'zipperposition: Found duplicate proof', 'zipperposition found a proof...', 'e: Found duplicate proof', 'verit: Found duplicate proof', 'zipperposition found a proof...', 'zipperposition: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_13_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Promotes :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Disrupts :: \"event \u21d2 bool\"\\n  EssentialFor :: \"event \u21d2 entity \u21d2 bool\"\\n  Disruption :: \"event \u21d2 bool\"\\n  DueTo :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevents :: \"event \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity\"\\n  Humans :: \"entity\"\\n  HomologousRecombinationRepair :: \"entity\"\\n\\n(* Explanation 1: Patient with loss of BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2. Patient x \u2227 LossOfBRCA2 y \u2227 RepairMolecules z \u2227 Joining e1 \u2227 Agent e1 z \u2227 Promotes e2 \u2227 Agent e2 x \u2227 Patient x \u2227 Via e1 RAD51Homolog1 \u2227 In e1 Humans\"\\n\\n(* Explanation 2: Loss of BRCA2 disrupts the joining of undamaged homologous repair molecules, which is essential for homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y e1 e2. LossOfBRCA2 x \u2227 RepairMolecules y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Disrupts e2 \u2227 Agent e2 x \u2227 Patient x \u2227 EssentialFor e1 HomologousRecombinationRepair\"\\n\\n(* Explanation 3: The disruption of the joining of undamaged homologous repair molecules due to the loss of BRCA2 prevents the joining in homologous recombination repair. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y e1 e2 e3. LossOfBRCA2 x \u2227 RepairMolecules y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Disruption e2 \u2227 Agent e2 y \u2227 DueTo e2 x \u2227 Prevents e3 \u2227 Agent e3 x \u2227 Patient x \u2227 In e1 HomologousRecombinationRepair\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"LossOfBRCA2 x \u2227 RepairMolecules y\"\\n  (* Hypothesis: Loss of BRCA2 prevents the joining of undamaged repair molecules in homologous recombination repair. *)\\n  shows \"\u2203x y e1 e2. LossOfBRCA2 x \u2227 RepairMolecules y \u2227 Joining e1 \u2227 Agent e1 y \u2227 Prevents e2 \u2227 Agent e2 x \u2227 Patient x \u2227 In e1 HomologousRecombinationRepair\"\\nproof -\\n  (* From the premise, we have the known information about the loss of BRCA2 and repair molecules. *)\\n  from asm have \"LossOfBRCA2 x \u2227 RepairMolecules y\" <ATP>\\n  (* Explanation 3 states that the disruption of the joining of undamaged homologous repair molecules due to the loss of BRCA2 prevents the joining in homologous recombination repair. *)\\n  (* We have a logical relation Implies(A, Not(D)), which means loss of BRCA2 implies not homologous recombination repair. *)\\n  (* Explanation 3 also provides that the disruption due to loss of BRCA2 prevents the joining in homologous recombination repair. *)\\n  (* Therefore, we can infer the prevention of joining in homologous recombination repair. *)\\n  then have \"\u2203e1 e2. Joining e1 \u2227 Agent e1 y \u2227 Prevents e2 \u2227 Agent e2 x \u2227 Patient x \u2227 In e1 HomologousRecombinationRepair\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: loss of BRCA2 (from Explanatory Sentence 1 and 2)\\nB: joining of undamaged homologous repair molecules via RAD51 homolog 1 (from Explanatory Sentence 1)\\nC: disruption of the joining of undamaged homologous repair molecules (from Explanatory Sentence 2)\\nD: homologous recombination repair (from Explanatory Sentence 2 and 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(loss of BRCA2, joining of undamaged homologous repair molecules via RAD51 homolog 1)\\n--------\\nImplies(A, C)\\nImplies(loss of BRCA2, disruption of the joining of undamaged homologous repair molecules)\\n--------\\nImplies(C, Not(D))\\nImplies(disruption of the joining of undamaged homologous repair molecules, Not(homologous recombination repair))\\n--------\\n\\nDerived Implications:\\nImplies(D, Not(A))\\nImplies(homologous recombination repair, Not(loss of BRCA2))\\n--------\\nImplies(A, Not(D))\\nImplies(loss of BRCA2, Not(homologous recombination repair))\\n--------\\n'}"
        ]
    }
}